Corneat Vision , Ltd.

Corneat Vision, Ltd. specializes in synthetic polymer surgical meshes that are classified as non-bioabsorbable. These devices are primarily designed for extra-gynaecological applications, such as reinforcing tissues in surgical procedures where long-term support is required. Examples include the CorNeat EverPatch, EverPatch+, and CorNeat EverPatch.

The company is headquartered in the United States. This location influences its regulatory compliance, particularly under U.S. authorities like the FDA.

The company’s devices are included in the FDA’s 510(k) premarket notification registry and the Unique Device Identifier (UDI) database. These registries track devices that have undergone FDA review for compliance with safety and effectiveness standards before market authorization.

All of Corneat Vision, Ltd.’s devices fall under FDA Class II classification. This classification applies to devices that generally pose moderate risk and require special controls—such as performance standards or post-market surveillance—to ensure their safety and effectiveness.